Systems biology of cisplatin resistance: past, present and future

L Galluzzi, I Vitale, J Michels, C Brenner… - Cell death & …, 2014 - nature.com
The platinum derivative cis-diamminedichloroplatinum (II), best known as cisplatin, is
currently employed for the clinical management of patients affected by testicular, ovarian …

Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress

ME Neganova, SG Klochkov, YR Aleksandrova… - Seminars in Cancer …, 2022 - Elsevier
Epigenetic changes associated with histone modifications play an important role in the
emergence and maintenance of the phenotype of various cancer types. In contrast to direct …

Epigenetic modifications and head and neck cancer: implications for tumor progression and resistance to therapy

RM Castilho, CH Squarize, LO Almeida - International journal of …, 2017 - mdpi.com
Head and neck squamous carcinoma (HNSCC) is the sixth most prevalent cancer and one
of the most aggressive malignancies worldwide. Despite continuous efforts to identify …

Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy

JS Carew, FJ Giles, ST Nawrocki - Cancer letters, 2008 - Elsevier
Histone deacetylases (HDACs) play an important role in the epigenetic regulation of gene
expression by catalyzing the removal of acetyl groups, stimulating chromatin condensation …

Epigenetics and cancer treatment

LS Kristensen, HM Nielsen, LL Hansen - European journal of …, 2009 - Elsevier
In addition to the genetic alterations, observed in cancer cells, are mitotically heritable
changes in gene expression not encoded by the DNA sequences, which are referred to as …

Epigenetic polypharmacology: A new frontier for epi‐drug discovery

D Tomaselli, A Lucidi, D Rotili… - Medicinal research …, 2020 - Wiley Online Library
Recently, despite the great success achieved by the so‐called “magic bullets” in the
treatment of different diseases through a marked and specific interaction with the target of …

Epigenetic mechanisms in oral carcinogenesis

JA Gasche, A Goel - Future oncology, 2012 - Taylor & Francis
Dysregulation of gene expression is a frequent occurrence in oral squamous cell carcinoma
(OSCC). However, accumulating evidence suggests that in contrast to genetics, epigenetic …

Epigenetic disregulation in oral cancer

M Mascolo, M Siano, G Ilardi, D Russo… - International journal of …, 2012 - mdpi.com
Squamous cell carcinoma of the oral region (OSCC) is one of the most common and highly
aggressive malignancies worldwide, despite the fact that significant results have been …

Combination therapy as a promising way to fight oral cancer

JPN Silva, B Pinto, L Monteiro, PMA Silva, H Bousbaa - Pharmaceutics, 2023 - mdpi.com
Oral cancer is a highly aggressive tumor with invasive properties that can lead to metastasis
and high mortality rates. Conventional treatment strategies, such as surgery, chemotherapy …

Development of vorinostat: current applications and future perspectives for cancer therapy

VM Richon, J Garcia-Vargas, JS Hardwick - Cancer letters, 2009 - Elsevier
Vorinostat is a potent histone deacetylase inhibitor that blocks the catalytic site of these
enzymes. A large number of cellular proteins are modified post-translationally by acetylation …